Health Canada
- Status: approved
Simulant agent for Zhi Kang Capsule (Simulant agent for Zhi Kang Capsule) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Peking University People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.